Sukhani told CNBC-TV18, "There is a theme, something is going on in pharma, and Cipla is making new highs and building on that. The same is happening with Dr Reddy which was the choice earlier. So Cipla is a buying opportunity and in a flat market you have to go to these stocks which usually are not momentum stocks. So it makes sense to go in for Cipla."
He further added, "One can buy it at the current prices, keep a stoploss at Rs 302. Again a target of Rs 330 is visible. Sometimes if we have a market like we saw yesterday, the targets may not be achieved today but they should come if the momentum is fair."
